Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04783350 · ClinicalTrials.gov registry record · NA
Home-based Brain Stimulation for Memory
A NA study, sponsored by Hebrew SeniorLife.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT04783350: Completed NA study, sponsored by Hebrew SeniorLife.
NCT04783350 is a NA study that has completed, run by Hebrew SeniorLife. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04783350, a NA study, has completed, sponsored by Hebrew SeniorLife.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The proposed project aims to systematically examine the feasibility of remote, caregiver-led tACS for older adults who are vulnerable to memory decline.
Primary Outcome
a trained clinician will administer the Montreal Cognitive Assessment (MOCA) to characterize cognitive status and the level of dementia
Interventions
- DEVICE Transcranial alternating current stimulation (tACS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2020-07-06 |
| Est. Completion | 2023-09-30 |
| Phase | NA |
What the finished NCT04783350 record still lists
NCT04783350 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Transcranial alternating current stimulation (tACS) is the first listed.
NCT04783350 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04783350 about?
NCT04783350 is a clinical study titled "Home-based Brain Stimulation for Memory". The proposed project aims to systematically examine the feasibility of remote, caregiver-led tACS for older adults who are vulnerable to memory decline.
What is the current status of trial NCT04783350?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2020-07-06. Estimated completion is 2023-09-30.
What interventions are being tested in trial NCT04783350?
The interventions under investigation include: Transcranial alternating current stimulation (tACS) (DEVICE).
Who is sponsoring clinical trial NCT04783350?
This trial is sponsored by Hebrew SeniorLife, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04783350's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI